Marius Messemaker
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- T-cell and B-cell Immunology
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immune cells in cancer 4
- Immunotherapy and Immune Responses 3
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 1
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
- Inflammatory Biomarkers in Disease Prognosis 1
- CAR-T cell therapy research 1
- Co-authors
- Mikaël J. Pittet (3 shared papers)Allon Moshe Klein (3 shared papers)Ruben Bill (2 shared papers)Genevieve M. Gerhard (2 shared papers)Ralph Weissleder (2 shared papers)Christina Pfirschke (2 shared papers)Jeremy Gungabeesoon (2 shared papers)Marie Siwicki (2 shared papers)
- Journals
- Cell (2 papers)Cell Reports (1 paper)Science (1 paper)The Journal of Experimental Medicine (1 paper)Science Immunology (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Marius Messemaker
6 papers receiving 1.4k citations
Marius Messemaker's Hit Papers
Peers
Comparison fields: 5 of 70
- Immunology 835
- Oncology 552
- Cancer Research 80
- Molecular Biology 296
- Immunology and Allergy 21
Countries citing papers authored by Marius Messemaker
This map shows the geographic impact of Marius Messemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marius Messemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marius Messemaker more than expected).
Fields of papers citing papers by Marius Messemaker
This network shows the impact of papers produced by Marius Messemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marius Messemaker. The network helps show where Marius Messemaker may publish in the future.
Co-authors
The 24 scholars most cited alongside Marius Messemaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers Hit paper breakdown → | 2023 | 427 |
| 2 | CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment Hit paper breakdown → | 2021 | 339 |
| 3 | A neutrophil response linked to tumor control in immunotherapy Hit paper breakdown → | 2023 | 308 |
| 4 | 2020 | 181 | |
| 5 | 2020 | 99 | |
| 6 | 2021 | 65 |
About Marius Messemaker
Marius Messemaker is a scholar working on Immunology, Oncology, Immunology and Allergy, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 6 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), Ferroptosis and cancer prognosis (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Cell Adhesion Molecules Research (1 paper), CAR-T cell therapy research (1 paper) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Immunology (835 citations), Oncology (552 citations), Cancer Research (80 citations), Molecular Biology (296 citations) and Immunology and Allergy (21 citations). Marius Messemaker has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Mikaël J. Pittet, Allon Moshe Klein, Ruben Bill, Genevieve M. Gerhard, Ralph Weissleder, Christina Pfirschke, Jeremy Gungabeesoon, Marie Siwicki, Michael C. Mazzola and Máté Kiss. Their work appears in journals such as Cell, Cell Reports, Science, The Journal of Experimental Medicine and Science Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.